Cargando…
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [(18)F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-he...
Autores principales: | Guglielmo, Priscilla, Alongi, Pierpaolo, Baratto, Lucia, Abenavoli, Elisabetta, Buschiazzo, Ambra, Celesti, Greta, Conte, Miriam, Filice, Rossella, Gorica, Joana, Jonghi-Lavarini, Lorenzo, Lanzafame, Helena, Laudicella, Riccardo, Librando, Maria, Linguanti, Flavia, Mattana, Francesco, Miceli, Alberto, Olivari, Laura, Piscopo, Leandra, Romagnolo, Cinzia, Santo, Giulia, Vento, Antonio, Volpe, Fabio, Evangelista, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533171/ https://www.ncbi.nlm.nih.gov/pubmed/37763225 http://dx.doi.org/10.3390/life13091821 |
Ejemplares similares
-
Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019) -
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics
por: Laudicella, Riccardo, et al.
Publicado: (2023) -
Clinical Impact of (18)F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Arnone, Annachiara, et al.
Publicado: (2020) -
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey
por: Annunziata, Salvatore, et al.
Publicado: (2020)